• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑硬脑膜动脉血管融合术(EDAS)在镰状细胞病患儿烟雾病综合征治疗中的应用

Encephaloduroateriosynangiosis (EDAS) in the management of Moyamoya syndrome in children with sickle cell disease.

作者信息

Alamri Alexander, Hever Pennylouise, Cheserem Jebet, Gradil Catia, Bassi Sanj, Tolias Christos M

机构信息

a Department of Neurosurgery , King's College Hospital , London , UK.

出版信息

Br J Neurosurg. 2019 Apr;33(2):161-164. doi: 10.1080/02688697.2017.1339227. Epub 2017 Jun 15.

DOI:10.1080/02688697.2017.1339227
PMID:28616936
Abstract

BACKGROUND

Encephalo-duro-arterio-synangiosis (EDAS) in Moyamoya syndrome (MMS) treatment has been well described in the literature, however in MMS caused by sickle cell anaemia (SCA), EDAS use remains controversial with poor long-term follow-up. We present a case-series of SCA patients who have undergone EDAS for SCA-related MMS and describe their post-operative course as well as provide a literature review of the role of EDAS in the treatment of sickle cell anaemia.

METHODS

A retrospective review of all the paediatric EDAS procedures conducted in our institution for SCA from 2007 to 2015. Two patients underwent behavioural screening.

RESULTS

A total of eight patients with MMS secondary to SCA underwent EDAS. Unilateral EDAS was performed without complication in seven patients. One patient underwent bilateral EDAS but with a two-year gap in between procedures. Follow-up magnetic resonance angiography demonstrated no progression of Moyamoya collaterals or further ischaemic events with regression of collaterals clearly visible in one patient. All patients have demonstrated a return to normal school activities.

CONCLUSIONS

EDAS is a well-tolerated revascularisation procedure for children with MMS. The prevention of further infarcts in our group with sickle cell disease has allowed these children to resume normal school activities.

摘要

背景

文献中已对烟雾病综合征(MMS)治疗中的脑-硬脑膜-动脉-血管吻合术(EDAS)进行了详细描述,然而在镰状细胞贫血(SCA)所致的MMS中,EDAS的应用仍存在争议,且长期随访情况不佳。我们报告一组因SCA相关MMS接受EDAS治疗的SCA患者病例系列,描述其术后病程,并对EDAS在镰状细胞贫血治疗中的作用进行文献综述。

方法

对2007年至2015年在我院为SCA进行的所有儿科EDAS手术进行回顾性研究。两名患者接受了行为筛查。

结果

共有8例继发于SCA的MMS患者接受了EDAS治疗。7例患者进行了单侧EDAS,无并发症发生。1例患者接受了双侧EDAS,但两次手术间隔两年。随访磁共振血管造影显示,烟雾病侧支循环无进展,也未发生进一步缺血事件,其中1例患者侧支循环明显消退。所有患者均已恢复正常学校活动。

结论

EDAS是一种耐受性良好的针对MMS患儿的血管重建手术。在我们的镰状细胞病患者组中,预防进一步梗死使这些儿童能够恢复正常学校活动。

相似文献

1
Encephaloduroateriosynangiosis (EDAS) in the management of Moyamoya syndrome in children with sickle cell disease.脑硬脑膜动脉血管融合术(EDAS)在镰状细胞病患儿烟雾病综合征治疗中的应用
Br J Neurosurg. 2019 Apr;33(2):161-164. doi: 10.1080/02688697.2017.1339227. Epub 2017 Jun 15.
2
Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.镰状细胞贫血患者烟雾病综合征的外科治疗:脑-硬脑膜-动脉血管融合术后的结果
J Neurosurg Pediatr. 2008 Mar;1(3):211-6. doi: 10.3171/PED/2008/1/3/211.
3
Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.脑硬脑膜动脉血管吻合术和脑肌动脉血管吻合术用于治疗镰状细胞病小儿患者的烟雾病综合征
J Neurosurg Pediatr. 2015 Jul;16(1):64-73. doi: 10.3171/2014.12.PEDS14522. Epub 2015 Apr 3.
4
Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.手术血运重建对镰状细胞病和烟雾病综合征患儿预防卒中的有效性。
J Neurosurg Pediatr. 2017 Sep;20(3):232-238. doi: 10.3171/2017.1.PEDS16576. Epub 2017 Jul 7.
5
The importance of encephalo-myo-synangiosis in surgical revascularization strategies for moyamoya disease in children and adults.脑-肌-血管融合术在儿童和成人烟雾病外科血管重建策略中的重要性。
World Neurosurg. 2015 May;83(5):691-9. doi: 10.1016/j.wneu.2015.01.016. Epub 2015 Feb 3.
6
Pial synangiosis for moyamoya syndrome in children with sickle cell anemia: a comprehensive review of reported cases.镰状细胞贫血儿童烟雾病的软脑膜血管吻合术:已报道病例的综合回顾。
Neurosurg Focus. 2014 Jan;36(1):E12. doi: 10.3171/2013.10.FOCUS13405.
7
Encephaloduroarteriosynangiosis (EDAS) in young patients with cerebrovascular complications of sickle cell disease: Single-institution experience.镰状细胞病脑血管并发症年轻患者的脑硬脑膜动脉血管融合术(EDAS):单机构经验
Pediatr Hematol Oncol. 2017 Mar;34(2):100-106. doi: 10.1080/08880018.2017.1313917. Epub 2017 May 22.
8
Reoperation for moyamoya disease refractory to encephalo-duro-arterio-synangiosis.脑-硬膜-动脉-血管融合术治疗难治性烟雾病的再次手术
Acta Neurochir (Wien). 1990;107(3-4):129-32. doi: 10.1007/BF01405791.
9
Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.烟雾病综合征和镰状细胞贫血患者的软脑膜血管吻合术:围手术期管理及手术结果
Neurosurg Focus. 2009 Apr;26(4):E10. doi: 10.3171/2009.01.FOCUS08307.
10
Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure.镰状细胞贫血合并烟雾病:脑-硬脑膜血管融通术(EDAS)后的结局
Pediatr Neurol. 2003 Aug;29(2):124-30. doi: 10.1016/s0887-8994(03)00047-x.

引用本文的文献

1
Encephaloduroarteriosynangiosis for the Treatment of Cerebral Arteriovenous Malformations in the Pediatric Population.脑硬脑膜动脉血管融合术治疗小儿脑动静脉畸形
Cureus. 2025 Apr 5;17(4):e81765. doi: 10.7759/cureus.81765. eCollection 2025 Apr.
2
Managing the Cerebrovascular Complications of Sickle Cell Disease: Current Perspectives.镰状细胞病脑血管并发症的管理:当前观点
J Blood Med. 2023 Apr 14;14:279-293. doi: 10.2147/JBM.S383472. eCollection 2023.
3
Surgical revascularizations for pediatric moyamoya: a systematic review, meta-analysis, and meta-regression analysis.
小儿烟雾病的外科血运重建术:系统评价、荟萃分析和荟萃回归分析。
Childs Nerv Syst. 2023 May;39(5):1225-1243. doi: 10.1007/s00381-023-05868-6. Epub 2023 Feb 8.
4
The contralateral progression in a cohort of Chinese adult patients with unilateral moyamoya disease after revascularization: a single-center long-term retrospective study.中国单侧烟雾病成年患者血管重建术后对侧进展:单中心长期回顾性研究。
Acta Neurochir (Wien). 2022 Jul;164(7):1837-1844. doi: 10.1007/s00701-022-05153-6. Epub 2022 Mar 26.
5
American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults.美国血液学会2020年镰状细胞病指南:儿童和成人脑血管疾病的预防、诊断和治疗
Blood Adv. 2020 Apr 28;4(8):1554-1588. doi: 10.1182/bloodadvances.2019001142.
6
Microduplication of 15q13.3 and Microdeletion of 18q21.32 in a Patient with Moyamoya Syndrome.患者患有烟雾病,存在 15q13.3 微重复和 18q21.32 微缺失。
Int J Mol Sci. 2018 Nov 20;19(11):3675. doi: 10.3390/ijms19113675.